spacer
home > pmps > autumn 2009 > technology tackles counterfeiting
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Technology Tackles Counterfeiting

 

Counterfeiters are more active globally than ever before, feeding on consumer needs for cheaper products, with several distribution channels available to them. Are we doing enough to fight counterfeiting and are we using the right approach? Do we have systems capable of dealing with this issue? A novel technology which uses embedded intelligence in the packaging that cannot be duplicated, thereby creating unique IDs allows for the ultimate fight against counterfeiters. It is time for us to take advantage of this and empower the consumer to verify authenticity.

Drug counterfeiting inhibits growth of legitimate products in the marketplace. In the current global environment, counterfeits are growing significantly to occupy an astounding 10 per cent of the global drug marketplace, according to published reports by the World Health Organization (WHO). The problem is not associated with specific geographic regions, but hits every facet of our global supply chain. If published data on counterfeit vaccines is any indication, things could get even worse if consumers end up using counterfeit H1N1 vaccines and other products. The frightening aspect of all of this is the great reliance on trust alone, because the consumer or brand owner does not have the ability to verify the authenticity of the product any time, anywhere. The life sciences industry is a key target because of its high value products and weak or broken links in the supply chain – essentially the lack of endto- end supply chain visibility. The weak link in the supply chains within countries need to be fixed in order to enhance visibility in the global supply chain.

This article also examines the different options used as security features on packaging, and discusses if we are encouraging the adoption of the best approach with serialised IDs. The article also discusses the embedded, noncopiable intelligence in every package based on its structure, and asks if we would be better off using this as part of any standardised approach, especially as it costs much less than some of the technologies currently used.

STRENGTHENING BUSINESS PROCESSES

A recent study in the EU, Building Radio frequency Identification solutions for the Global Environment (BRIDGE), reported that full supply chain traceability of pharmaceutical products is entirely feasible in an open cross-border supply chain system, when using accepted standards.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Narendra Srivatsa is responsible for Cortegra’s packaging solutions and services for the healthcare industry. He has developed and launched the RxTrackNSecureTM brand to the pharmaceutical industry. Prior to joining Cortegra, he spent 15 years in a number of different key roles at International Paper, leading them into new products and markets. Narendra has been awarded numerous process and product patents, many of which have been commercialised or licensed. He has authored articles in many leading trade publications and has also developed and presented the training module on ‘RFID Enhanced Packaging’ as part of a day long training on ‘RFID in the Life Sciences’ presented at the Interphex 2005 and Interphex 2006.
spacer
Narendra Srivatsa
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region. Government incentive schemes to increase domestic production, coupled with a brand friendly environment and rising healthcare needs is fuelling surging demand – with many new companies and plants launching in the last two years alone.
More info >>

White Papers

A Rules Based Approach to Labelling and Artwork Management

Kallik

Many organisations today are experiencing unprecedented demands from regulatory authorities and consumers alike for product labelling to be made clearer and more informative. Forthcoming regulations (including the new EU MDR regulations coming into force May 2020) also require that labelling content to be published electronically in addition to print. As companies seek to continuously differentiate themselves in established markets as well as gain entry into new territories, the increase in both volume and complexity of product and market variations will have a direct impact on labelling.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement